Microdystrophin delivery in dystrophin-deficient (mdx) mice by genetically-corrected syngeneic MSCs transplantation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplantation Proceedings

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.transproceed.2010.04.031PMID 20832578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice.

  2008cited by this paper
• [Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice].

  2008cited by this paper
• Adeno-Associated Virus Serotype-9 Microdystrophin Gene Therapy Ameliorates Electrocardiographic Abnormalities in mdx Mice

  2008cited by this paper
• Transduction of full-length dystrophin to multiple skeletal muscles improves motor performance and life span in utrophin/dystrophin double knockout mice.

  2008cited by this paper
• Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice

  2008cited by this paper
• Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport

  2007cited by this paper
• Herpes Simplex Virus VP22 Enhances Adenovirus-Mediated Microdystrophin Gene Transfer to Skeletal Muscles in Dystrophin-Deficient (mdx) Mice

  2007cited by this paper
• Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.

  2007cited by this paper
• [Construction of recombinant adenovirus including microdystrophin and expression in the mesenchymal cells of mdx mice].

  2007cited by this paper
• Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.

  2006cited by this paper
• Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft.

  2006cited by this paper
• Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.

  2006cited by this paper
• Haemopoietic stem cell transplantation for genetic disorders

  2005cited by this paper
• Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

  2005cited by this paper
• Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration

  2005cited by this paper
• Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.

  2005cited by this paper
• Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

  2005cited by this paper
• Intraarterial Delivery of Naked Plasmid DNA Expressing Full-Length Mouse Dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy

  2004cited by this paper
• Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA

  2004cited by this paper
• [Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells].

  2004cited by this paper
• Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells.

  2004cited by this paper
• Dystrophin Delivery in Dystrophin-Deficient DMDmdx Skeletal Muscle by Isogenic Muscle-Derived Stem Cell Transplantation

  2003cited by this paper
• Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane

  2003cited by this paper
• Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

  2003cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003cited by this paper
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002cited by this paper
• Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

  2002cited by this paper
• Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds.

  2002cited by this paper
• Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

  2002cited by this paper
• Stem cells and aging: expanding the possibilities.

  2001cited by this paper
• Suppression of revertant fibers in mdx mice by expression of a functional dystrophin.

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

  2000cited by this paper
• Dystrophin expression in the mdx mouse restored by stem cell transplantation

  1999cited by this paper
• Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.

  1998cited by this paper
• Duchenne muscular dystrophy

  1995cited by this paper
• Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

  1991cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper

• Co-culture strategies for muscle-fat tissue development from caprine satellite cells: a step toward sustainable cultivated meat.

  2025cites this paper
• Stem Cell-Based Therapeutic Approaches in Genetic Diseases.

  2023cites this paper
• Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery

  2021cites this paper
• Limb Girdle Muscular Dystrophy and Therapy: Current progress in Cell and Gene-based approaches.

  2020cites this paper
• Biomarkers of Duchenne muscular dystrophy: current findings

  2018cites this paper
• Adipose-derived stem cells enhance myogenic differentiation in the mdx mouse model of muscular dystrophy via paracrine signaling

  2016cites this paper
• Activation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice

  2016cites this paper
• Concise Review: Mesoangioblast and Mesenchymal Stem Cell Therapy for Muscular Dystrophy: Progress, Challenges, and Future Directions

  2015cites this paper
• In Vitro Differentiation of Muscle Side Population Cells from Dystrophic Muscle Reveals Absence of Myogenesis and Implications for Hedgehog Signaling

  2013cites this paper
• Translational Research in Stem Cell Treatment of Neuromuscular Diseases

  2013cites this paper
• Advances in Lentiviral Vector-based Cell Therapy with Mesenchymal Stem Cells

  2012cites this paper
• Cell–matrix interactions in muscle disease

  2012cites this paper